CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Efficacy and tolerance of treatments received beyond progression in men with metastatic hormone-naive prostate cancer treated with androgen deprivation therapy (ADT) with or without docetaxel in the GETUG-AFU 15 phase III trial.
Author
Brigitte Laguerre
Christine Theodore
+18Â more
Clemence Legoupil
Florence Joly
Franck Priou
Gabrielle Tergemina-Clain
Gwenaelle Gravis
Igor Latorzeff
Ivan Krakowski
Jean Marc Ferrero
Jean Marie Boher
Karim Fizazi
Loic Mourey
Michel Soulie
Muriel Habibian
Pernelle Lavaud
Philippe Beuzeboc
Remy Delva
Stephane Oudard
Stephanie Foulon
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
No full text
